SCNI (Scinai Immunotherapeutics Ltd. American Depositary Shares) Stock Analysis - SEC Filings

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of May 20, 2026, SCNI trades at $0.48 with a market cap of $2.22M and a P/E ratio of 0.00. SCNI moved -3.56% today. Year to date, SCNI is -30.35%; over the trailing twelve months it is -81.98%. Its 52-week range spans $0.45 to $6.18. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find SCNI SEC filings?

Rallies organizes SCNI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

SCNI Key Metrics

Key financial metrics for SCNI
MetricValue
Price$0.48
Market Cap$2.22M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$6.18
52-Week Low$0.45
Volume792.02K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest SCNI News

Recent SCNI Insider Trades

  • BEATY ELWIN M bought 80.00K (~$5.20K) on Dec 14, 2007.
  • BEATY ELAINE E bought 80.00K (~$5.20K) on Dec 14, 2007.
  • BEATY ELWIN M sold 80.00K (~$5.20K) on Dec 14, 2007.

SCNI Analyst Consensus

SCNI analyst coverage data. Average price target: $0.00.

Common questions about SCNI

Where can I find SCNI SEC filings?
Rallies organizes SCNI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show SCNI 10-K and 10-Q filings?
Rallies organizes SCNI SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is SCNI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNI. It does not provide personalized investment advice.
SCNI

SCNI